English | Español
Patient Daily | Feb 4, 2026

Leaders urged to prioritize subtraction of old tasks for successful goal execution
Patient Daily | Feb 4, 2026

Lilly partners with Seamless Therapeutics on $1.12B+ gene editing deal for hearing loss
Patient Daily | Feb 4, 2026

Cellares raises $257M for expansion of automated cell therapy manufacturing
Patient Daily | Feb 4, 2026

Roche reports positive results in obesity drug trial; Moderna halts vaccine studies
Patient Daily | Feb 4, 2026

FDA holds up REGENXBIO's Hunter syndrome program; Denali may move ahead
Patient Daily | Feb 4, 2026

Cardiff Oncology faces executive departures and mixed phase II trial results
Patient Daily | Feb 4, 2026

FDA approves new frontline use for J&J's Darzalex Faspro in multiple myeloma
Patient Daily | Feb 4, 2026

Baylor College team develops method for sustained laboratory growth of human norovirus

Trending
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
A. R. Baird | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science